A variant at chromosome 9 p 21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome

Citation for published version: Buysschaert, I, Carruthers, KF, Dunbar, DR, Peuteman, G, Rietzschel, E, Belmans, A, Hedley, A, De Meyer, T, Budaj, A, Van de Werf, F, Lambrechts, D & Fox, KAA 2010, 'A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics Study' European Heart Journal, vol. 31, no. 9, pp. 1132-41. DOI: 10.1093/eurheartj/ehq053

[1]  Russ Wolfinger,et al.  SNP selection and multidimensional scaling to quantify population structure , 2009, Genetic epidemiology.

[2]  E. Boerwinkle,et al.  A genetic variant on chromosome 9p21 and incident heart failure in the ARIC study. , 2009, European heart journal.

[3]  B. Horne,et al.  Association of Variation in the Chromosome 9p21 Locus With Myocardial Infarction Versus Chronic Coronary Artery Disease , 2008, Circulation. Cardiovascular genetics.

[4]  Florian Kronenberg,et al.  Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. , 2008, Journal of the American College of Cardiology.

[5]  Ludwig A Hothorn,et al.  Repeated Replication and a Prospective Meta-Analysis of the Association Between Chromosome 9 p 21 . 3 and Coronary Artery Disease , 2008 .

[6]  Stefan Lorkowski,et al.  Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. , 2008, Human molecular genetics.

[7]  A. Quyyumi,et al.  Familial aggregation of left main coronary artery disease and future risk of coronary events in asymptomatic siblings of affected patients. , 2008, European heart journal.

[8]  H. Stefánsson,et al.  The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm , 2008, Nature Genetics.

[9]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[10]  C. Gieger,et al.  Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.

[11]  A. Gylfason,et al.  A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction , 2007, Science.

[12]  Pascal Verdonck,et al.  Rationale, design, methods and baseline characteristics of the Asklepios Study , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[13]  Jonathan C. Cohen,et al.  A Common Allele on Chromosome 9 Associated with Coronary Heart Disease , 2007, Science.

[14]  K. Eagle,et al.  Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) , 2006, BMJ : British Medical Journal.

[15]  J. Thompson,et al.  The choice of a genetic model in the meta-analysis of molecular association studies. , 2005, International journal of epidemiology.

[16]  Steven Hawken,et al.  Preventive cardiologyAbstractsEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study , 2004 .

[17]  Paul Oeth,et al.  MALDI-TOF mass spectrometry , 2004, Molecular biotechnology.

[18]  F. Roche.  Predictors of 90-day outcome in patients stabilized after acute coronary syndromes , 2003 .

[19]  Grace Investigators,et al.  Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. , 2001, American heart journal.

[20]  E. Antman,et al.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.

[21]  E W Steyerberg,et al.  Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. , 2000, Circulation.

[22]  K. Mizuno,et al.  Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. , 1992, The New England journal of medicine.

[23]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.